Enterocele
9
2
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
SCP vs HUSLS for Pelvic Organ Prolapse Repair
Biological OviTex Versus Synthetic Graft in Robotic Prolapse Surgery
Recurrence and Bowel Function After Laparoscopic Vaginorectopexy, a Modified Anterior Rectopexy
Multicenter Ventral Mesh Rectopexy Registry Collaborative
A Study Evaluating the Clinical Outcome of a Modified d'Hoore Technique for Laparoscopic Ventral Mesh Rectopexy
Sacrocolpopexy Versus Vaginal Mesh Procedure for Pelvic Prolapse
Laser Therapy in Managing Vaginal Prolapse
Clinical Performance of the GYNECARE PROLIFT + M* Pelvic Floor Repair System as a Device for Pelvic Organ Prolapse
Prophylactic Antibiotic Treatment During Vaginal Repair